Literature DB >> 10830722

Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.

L S St John1, E R Sauter, M Herlyn, S Litwin, K Adler-Storthz.   

Abstract

Prior reports suggest that p53 protein status may influence the response to gene transduction with wild-type (wt) p53. Adenoviral vectors containing the p53 gene were administered to normal keratinocytes, to squamous cell carcinoma (SCC) lines with varied p53 protein status (absent, mutant, wt, or degraded by papillomavirus), as well as to tumors formed in severe combined immunodeficient mice. The percentage of cells undergoing apoptosis, G1 growth arrest, WAF1/p21 induction, and in vivo tumor progression were studied after wt p53 gene transduction. Apoptosis developed first in normal keratinocytes, next in SCCs lacking p53 protein, and last in SCCs with mutant or degraded p53 protein. All of the cell lines studied demonstrated an increase in WAF1/p21 protein, but only those lacking p53 protein showed G1 arrest. Tumors lacking p53 protein were more susceptible to p53 overexpression than those containing mutant or degraded p53 protein. The endogenous p53 protein status of SCCs appears to influence the outcome of p53 gene transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10830722     DOI: 10.1038/sj.cgt.7700166

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  14 in total

1.  Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.

Authors:  Eiichi Makino; Masakiyo Sakaguchi; Keiji Iwatsuki; Nam-ho Huh
Journal:  J Mol Med (Berl)       Date:  2004-07-06       Impact factor: 4.599

2.  Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different.

Authors:  Rosemarie Krupar; Katharina Robold; Doris Gaag; Gerrit Spanier; Marina Kreutz; Kathrin Renner; Claus Hellerbrand; Ferdinand Hofstaedter; Anja K Bosserhoff
Journal:  Virchows Arch       Date:  2014-07-16       Impact factor: 4.064

3.  Comparison of As(2)O(3) and As(4)O(6) in the detection of SiHa cervical cancer cell growth inhibition pathway.

Authors:  Yong Wook Kim; Su Mi Bae; Keun Ho Lee; Joon Mo Lee; Sung Eun Namkoong; Insu P Lee; Chong Kook Kim; Jeong-Sun Seo; Jeong-Im Sin; Yong-Wan Kim; Woong Shick Ahn
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

4.  The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viability.

Authors:  April L Risinger; Mohan Natarajan; Charles R Thomas; Susan L Mooberry
Journal:  Cancer Lett       Date:  2011-04-19       Impact factor: 8.679

5.  Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes.

Authors:  Yi-Hua Jan; Diane E Heck; Yunqi An; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2022-03-21       Impact factor: 3.973

6.  Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa.

Authors:  Jeong Kim; Su-Mi Bae; Dae-Seog Lim; Sun-Young Kwak; Chang-Ki Lee; Yong-Seok Lee; Il-Ju Bae; Jin-Young Yoo; Young-Joo Lee; Chong-Kook Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

7.  Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist.

Authors:  Luz E Tavera-Mendoza; Tan D Quach; Basel Dabbas; Jonathan Hudon; Xiaohong Liao; Ana Palijan; James L Gleason; John H White
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

8.  Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progression.

Authors:  Amrendra K Ajay; Ankur K Upadhyay; Sandeep Singh; Maleppillil V Vijayakumar; Ratna Kumari; Vimal Pandey; Ramanamurthy Boppana; Manoj K Bhat
Journal:  Mol Cancer       Date:  2010-07-31       Impact factor: 27.401

9.  Id3 induces an Elk-1-caspase-8-dependent apoptotic pathway in squamous carcinoma cells.

Authors:  You-Shin Chen; Joseph Aubee; Kyle A DiVito; Hengbo Zhou; Weiyi Zhang; Fen-Pi Chou; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Cancer Med       Date:  2015-02-18       Impact factor: 4.452

10.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.